These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 11651270)

  • 41. Rate of refusal to participate in clinical trials.
    Shimm DS; Spece RG
    IRB; 1992; 14(2):7-9. PubMed ID: 11651246
    [No Abstract]   [Full Text] [Related]  

  • 42. Human experimentation. Protecting patient autonomy through informed consent.
    Tuthill KA
    J Leg Med; 1997 Jun; 18(2):221-50. PubMed ID: 9230568
    [No Abstract]   [Full Text] [Related]  

  • 43. Institutional review boards in the university setting: review of pharmaceutical testing protocols, informed consent and ethical concerns.
    Kobasic DM
    J Coll Univ Law; 1988; 15(2):185-216. PubMed ID: 11659168
    [No Abstract]   [Full Text] [Related]  

  • 44. Research ethics committees.
    Chalmers I
    BMJ; 1990 Feb; 300(6721):395-6. PubMed ID: 11653874
    [No Abstract]   [Full Text] [Related]  

  • 45. Minors' assent, consent, or dissent to medical research.
    Leikin S
    IRB; 1993; 15(2):1-7. PubMed ID: 11651566
    [No Abstract]   [Full Text] [Related]  

  • 46. Ethical issues in randomised prevention trials.
    Brezinova V; Shaw AB
    BMJ; 1992 Mar; 306(6880):790. PubMed ID: 11654018
    [No Abstract]   [Full Text] [Related]  

  • 47. International research: ethical imperialism or ethical pluralism?
    Macklin R
    Account Res; 1999; 7(1):59-83. PubMed ID: 11657563
    [No Abstract]   [Full Text] [Related]  

  • 48. Ethical aspects of pharmaceutically-based clinical investigation: report on a national workshop.
    Miller J; Kinsella D; Klein A; Rusted I
    NCBHR Commun; 1990; 1(1):7-10. PubMed ID: 11660185
    [No Abstract]   [Full Text] [Related]  

  • 49. Proposal for a good clinical practice directive.
    European Commission
    Bull Med Ethics; 1998 Feb; No. 135():6-11. PubMed ID: 11657249
    [No Abstract]   [Full Text] [Related]  

  • 50. The case for per patient payments.
    Lewis JP
    IRB; 1988; 10(5):9. PubMed ID: 11650075
    [No Abstract]   [Full Text] [Related]  

  • 51. Deception and the placebo effect in biomedical research.
    Connelly RJ
    IRB; 1987; 9(4):5-7. PubMed ID: 11649948
    [No Abstract]   [Full Text] [Related]  

  • 52. 50 years of clinical trials: past, present and future.
    Joule N
    Bull Med Ethics; 1998 Oct; No. 142():22-4. PubMed ID: 11657764
    [No Abstract]   [Full Text] [Related]  

  • 53. Consent to incomplete disclosure as an alternative to deception: case study.
    Levine RJ
    IRB; 1982 Dec; 4(10):9-11. PubMed ID: 11651795
    [No Abstract]   [Full Text] [Related]  

  • 54. Clinical mistrials.
    Dixon B
    Sciences (New York); 1982 Oct; 22(7):11. PubMed ID: 11650585
    [No Abstract]   [Full Text] [Related]  

  • 55. Emergency trials 'by popular consent.
    Kiernan V
    New Sci; 1995 Nov; 148(2002):6. PubMed ID: 11656475
    [No Abstract]   [Full Text] [Related]  

  • 56. Informed consent: the FDA's perspective.
    Bagley G
    Food Drug Law J; 1993; 48(2):181-6. PubMed ID: 11653141
    [No Abstract]   [Full Text] [Related]  

  • 57. Whose patient is this, anyway?
    Grodin MA; Sassower R
    IRB; 1987; 9(2):6-7. PubMed ID: 11649902
    [No Abstract]   [Full Text] [Related]  

  • 58. AIDS: patient power puts research on trial.
    Campbell D
    New Sci; 1988 Nov; 120(1638):26-7. PubMed ID: 11655899
    [No Abstract]   [Full Text] [Related]  

  • 59. Approving high risk, rejecting low risk: the case of two cases.
    Shannon TA; Ockene IS; Levine RJ
    IRB; 1985; 7(1):6-8. PubMed ID: 11649618
    [No Abstract]   [Full Text] [Related]  

  • 60. Learning about randomised controlled trials.
    Thornton H
    Bull Med Ethics; 1993 Apr; No. 87():21-3. PubMed ID: 11654062
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.